Clinical Trial

A Clinical Study to Assess the Safety and Effectiveness of Dharasana Lep in Patients With Mild to Moderate Muscular, Joint, or Rheumatic Pain

Completed
View on ClinicalTrials.gov →
Summary
A Prospective, Open-Label, Single-Centre Interventional Study to Evaluate the Efficacy and Safety of Dharasana Lep in Patients with Mild to Moderate Musculoskeletal Pain and Rheumatoid Arthritis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-18.
Status change: Not Yet Recruiting → Completed 2026-04-07
Trial Details
NCT Number NCT07085780
Lead Sponsor NovoBliss Research Pvt Ltd
Collaborators: Shah Maganlal Chunilal Gandhi
Conditions Musculoskeletal Pain, Rheumatic Pain
Enrollment 35 participants
Start Date 2025-07-28
Primary Completion 2025-09-15 (estimated)
Study Completion 2025-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-13